Clinical update from ongoing MP0533 phase 1/2a dose escalation study confirms overall acceptable safety profile observed so far and initial ...

Presenters are kindly asked not to exceed the size of the board. Posters presented in the Sessions are asked to be set-up during the lunch break on the day of presentation. Posters must be taken down ...

To help us make on demand presentations as accessible as possible, we need your help making sure the automatic captions are accurate. Your poster is your content. The ESA meeting platform will only ...

PharmaJet Poster Presentation at Cancer Immunotherapy Conference Highlights How Needle-free Technology is Enhancing Oncology ...

Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III Session Date: Monday, December 9, 2024 Presentation Time ... concerning these and other risk factors affecting our business can ...

DIJON, France--(BUSINESS WIRE)--Regulatory News ... Professor of Gastroenterology at CHRU of Nancy. "This presentation provides strong evidence that OPM has the potential to advance the treatment ...

allowing for control of tumors in vivo without the need for exogenous or engineered cytokines – – Posters include demonstration of advances in gene editing and transgene design that enable greater ...

--(BUSINESS WIRE)--Perosphere (Perosphere Technologies ... non-medicated subjects. Oral Poster Presentation Title: Clinical Performance of a Novel Point-of-Care Coagulometer for the DOACs ...

At the 2024 Educational Research and Innovations in Clinical and Health Sciences (ENRICH) Week poster session, Hunter “Caroline ... Davies also received first place overall for an oral presentation at ...

November 05, 2024--(BUSINESS WIRE)--ReAlta Life Sciences ... inflammatory response to address rare and acute inflammatory ...

The poster presentation details are as follows ... and Molecular Partners' expected business and financial outlook, including anticipated expenses and cash utilization for 2024 and its expectation ...